NCT04773223

Brief Summary

Background: Open repair remains the gold standard for fit patients with complex AAA. In the past decade, an evolution of devices, design, components, and delivery systems expanded the application of EVAR in these challenging anatomies. Fenestrated stent-grafts are now commercially available for the repair of complex AAA in the United States and Europe. Initial reports have demonstrated a high technical success rate, low renal dysfunction rate, and low morbidity and mortality, with promising short- and long-term results. Other reports have shown excessive morbidity and mortality with fenestrated EVAR (FEVAR). Studies comparing endovascular and open repair are sparse, especially when it concerns long-term outcomes. There are till nowadays only two propensity score-matched studies, one showing worse short-term and another long-term clinical outcome for fenestrated-branched EVAR (F/BEVAR) over open surgical repair (OSR). Aim: The aim of this study will be to compare F/BEVAR versus open AAA repair on short- and long-term clinical outcomes for the treatment of juxta- and pararenal AAA. Methodology: This is a prospective cohort study from the four high-volume AAA repair centers: Belgrade/Serbia, Bologna/Italy, Milan/Italy, Dijklander/Netherland, Amsterdam/Netherland, and Helsinki/Finland. Data will be collected on demographics, baseline comorbidities, AAA parameters (diameter and localization), laboratory values, intra-, and postoperative data. Follow-up examinations (clinical visits and color duplex ultrasonography, CT scans) will be performed 1, 6, and 12 months after the intervention, and annually thereafter. Propensity score analysis will be performed by matching open repair patients to endovascularly treated controlling for demographics and baseline comorbidities. Endpoints: Primary endpoints are all-cause mortality and the freedom from aortic-related reintervention. The secondary endpoint is the 30-day complication rate, especially acute kidney injury according to the RIFLE criteria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
925

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
10.1 years until next milestone

First Submitted

Initial submission to the registry

February 20, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

July 22, 2024

Completed
Last Updated

July 22, 2024

Status Verified

February 1, 2024

Enrollment Period

11 years

First QC Date

February 20, 2021

Results QC Date

February 6, 2024

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Aortic Related Reintervention.

    In open surgery this will include patients who were reoperated due to: graft infection, graft thrombosis, pseudoaneurysm formation, secondary AAA rupture. In endovascular group reintervention will include different reasons: endoleak, migration, thrombosis, infection, fracture, secondary AAA rupture.

    through study completion, an average of 7 year

  • All-cause Mortality

    Any cause of mortality duing follow-up period

    through study completion, an average of 7 year

Secondary Outcomes (1)

  • 30-day Acute Kidney Injury

    30-day acute kidney injury

Study Arms (2)

Open surgery group

Patients undergoing open surgery due to juxta/pararenal abdominal aortic aneurysm

Procedure: Open surgery and complex EVAR due to AAA

Endovascular group

Patients undergoing some form of endovascular abdominal aortic aneurysm repair: fenestrated, chimney, etc.

Procedure: Open surgery and complex EVAR due to AAA

Interventions

There will be two cohorts: 1. Patient undergoing open surgery 2. Patients undergoing complex endovascular repair (fenestrated, chimney, etc.)

Endovascular groupOpen surgery group

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility Detailsmore than 18 year old
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with juxta/pararenal abdominal aortic aneurysm (AAA) undergoing either open surgery or complex endovascular repair. The definition of the juxtarenal AAA will include those with a short neck (less than 1cm). The definition of the pararenal AAA will include those where renal arteries originate from the aneurysm itself.

You may qualify if:

  • All patients (over 18 years of age) with a history of juxta- and pararenal AAA repair from January 2011 to January 2022
  • All management strategies will be included (endovascular and open)

You may not qualify if:

  • Patients who are pregnant
  • Patients who are under 18 years of age
  • Patients who have ruptured AAA
  • Patients with thoracoabdominal aortic aneurysm (ThAAA)
  • Patients who have a mycotic AAA
  • Patients with connective tissue disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Center of Serbia

Belgrade, 11000, Serbia

Location

Related Publications (4)

  • Tinelli G, Crea MA, de Waure C, Di Tanna GL, Becquemin JP, Sobocinski J, Snider F, Haulon S. A propensity-matched comparison of fenestrated endovascular aneurysm repair and open surgical repair of pararenal and paravisceral aortic aneurysms. J Vasc Surg. 2018 Sep;68(3):659-668. doi: 10.1016/j.jvs.2017.12.060. Epub 2018 Mar 22.

    PMID: 29576405BACKGROUND
  • Raux M, Patel VI, Cochennec F, Mukhopadhyay S, Desgranges P, Cambria RP, Becquemin JP, LaMuraglia GM. A propensity-matched comparison of outcomes for fenestrated endovascular aneurysm repair and open surgical repair of complex abdominal aortic aneurysms. J Vasc Surg. 2014 Oct;60(4):858-63; discussion 863-4. doi: 10.1016/j.jvs.2014.04.011. Epub 2014 May 15.

    PMID: 24835042BACKGROUND
  • Roy IN, Millen AM, Jones SM, Vallabhaneni SR, Scurr JRH, McWilliams RG, Brennan JA, Fisher RK. Long-term follow-up of fenestrated endovascular repair for juxtarenal aortic aneurysm. Br J Surg. 2017 Jul;104(8):1020-1027. doi: 10.1002/bjs.10524. Epub 2017 Apr 12.

    PMID: 28401533BACKGROUND
  • Ferrante AM, Moscato U, Colacchio EC, Snider F. Results after elective open repair of pararenal abdominal aortic aneurysms. J Vasc Surg. 2016 Jun;63(6):1443-50. doi: 10.1016/j.jvs.2015.12.034. Epub 2016 Mar 16.

    PMID: 26994948BACKGROUND

Results Point of Contact

Title
Petar Zlatanovic
Organization
University Clinical Centre of Serbia

Study Officials

  • Petar Zlatanovic, MD

    University Clinical Centre of Serbia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

February 20, 2021

First Posted

February 26, 2021

Study Start

January 1, 2011

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

July 22, 2024

Results First Posted

July 22, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

This will be not available freely online, but on the request.

Locations